FDA Adverse Event Injury Summary report: N

OT ULTRA2 METER

MDR report key: 3901214 · Received June 30, 2014

Report

Report Number
2939301-2014-15773
Event Type
Injury
Date Received
June 30, 2014
Report Date
June 17, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K053529
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2014, THE LAY-USER/PATIENT CONTACTED LIFESCAN (LFS) USA, ALLEGING THAT THE ONETOUCH ULTRA2 METER IS GIVING INACCURATE HIGH OF ¿85 MG/DL¿ COMPARED FEELING/NORMAL READINGS. THIS COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. ON (B)(6) 2014 AT 12:10 AM, SHE REPORTEDLY TOOK 3 UNITS OF HUMALOG BASED ON AN ALLEGEDLY INACCURATE HIGH LFS METER READING. IN ADDITION, THE PATIENT TOOK 60 UNITS OF LEVEMIR THAT DAY. AROUND 10 HOURS LATER, AT 9:45 AM, THE PATIENT REPORTEDLY DEVELOPED SYMPTOM OF ¿SHAKY¿ AND TESTED ON ANOTHER METER, REPORTEDLY RECEIVING A ¿LOW READING.¿ THERE WAS NO REPORT OF ANY REQUIRED HCP TREATMENT AT THE TIME OF CONCERN. DURING THE TROUBLESHOOTING, THE PATIENT CONFIRMED THE UNIT OF MEASUREMENT WAS SET CORRECTLY AT THE TIME OF TESTING. THE TEST STRIPS WERE GOOD CONDITION AND WITHIN THE DISCARD DATE. THE PATIENT COULD NOT PROVIDE ANY NUMERIC VALUES ON THE OTHER METER. THIS COMPLAINT IS BEING REPORTED BECAUSE, THE PATIENT DEVELOPED SYMPTOM THAT CAN BE SUGGESTIVE OF HYPOGLYCEMIC AFTER SHE TOOK INSULIN BASED ON THE LFS METER READING. THE LFS PRODUCTS WERE REPLACED AND REQUESTED BACK FOR INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
380753 OT ULTRA2 METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3421595

Patients

Seq Age Sex Outcome Treatment
1 44 YR Life Threatening